Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation

被引:67
作者
Kim, Sanggu [1 ]
Ng, Wai Kiong [1 ]
Dong, Yuancai [1 ]
Das, Surajit [1 ]
Tan, Reginald B. H. [1 ,2 ]
机构
[1] Agcy Sci Technol & Res, Inst Chem & Engn Sci, Formulat Sci Grp Crystallizat & Particle Sci, Singapore 62783, Singapore
[2] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore
关键词
trans-Resveratrol nanoparticles; Temperature-controlled antisolvent precipitation; Freeze drying; Bioavailability; Saturation solubility; Dissolution rate; CANCER CHEMOPREVENTIVE ACTIVITY; DISSOLUTION RATE; CIS-RESVERATROL; DRUG PARTICLES; SIZE; MICRONIZATION; FORMULATION;
D O I
10.1016/j.jfoodeng.2011.07.034
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In order to enhance the oral bioavailability, trans-resveratrol (t-RVT) nanoparticles were prepared by temperature-controlled antisolvent precipitation with the hydroxypropyl methylcellulose as the stabilizer. The mean particle size was reduced by decreasing the precipitation temperature, mainly due to the higher nucleation rate and slower growth rate. The freeze dried t-RVT nanoparticles were well reconstituted in aqueous solution maintaining a similar particle size and distribution in the nanosize range that is prior to freeze drying without the aid of cryoprotectants. The SEM images exhibited some aggregation of individual spherical nanosized particles. The FT-IR analysis confirmed that the molecular structure of t-RVT nanoparticles was not changed after the precipitation process. Furthermore, t-RVT nanoparticles showed significantly enhanced saturation solubility and dissolution rate by the decrease in particle size and degree of crystallinity when compared to the raw t-RVT. The combined results have demonstrated that this method can considerably enhance the bioavailability of t-RVT. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 35 条
  • [1] Freeze-drying of nanoparticles: Formulation, process and storage considerations
    Abdelwahed, Wassim
    Degobert, Ghania
    Stainmesse, Serge
    Fessi, Hatem
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) : 1688 - 1713
  • [2] Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
    Basly, JP
    Marre-Fournier, F
    Le Bail, JC
    Habrioux, G
    Chulia, AJ
    [J]. LIFE SCIENCES, 2000, 66 (09) : 769 - 777
  • [3] Therapeutic potential of resveratrol:: the in vivo evidence
    Baur, Joseph A.
    Sinclair, David A.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) : 493 - 506
  • [4] Cancer chemopreventive activity of resveratrol
    Bhat, KPL
    Pezzuto, JM
    [J]. ALCOHOL AND WINE IN HEALTH AND DISEASE, 2002, 957 : 210 - 229
  • [5] Biological effects of resveratrol
    Bhat, KPL
    Kosmeder, JW
    Pezzuto, JM
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (06) : 1041 - 1064
  • [6] The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; Protection against LDL oxidation
    Brito, P
    Almeida, LM
    Dinis, TCP
    [J]. FREE RADICAL RESEARCH, 2002, 36 (06) : 621 - 631
  • [7] Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC:: application to pharmacokinetic studies
    Chen, Xijing
    He, Hui
    Wang, Guangji
    Yang, Bing
    Ren, Weichao
    Ma, Le
    Yu, Qiaoling
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (03) : 257 - 265
  • [8] Recent advances in the liquid-phase syntheses of inorganic nanoparticles
    Cushing, BL
    Kolesnichenko, VL
    O'Connor, CJ
    [J]. CHEMICAL REVIEWS, 2004, 104 (09) : 3893 - 3946
  • [9] Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis
    Docherty, JJ
    Fu, MM
    Tsai, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) : 243 - 244
  • [10] Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation
    Dong, Yuancai
    Ng, Wai Kiong
    Shen, Shoucang
    Kim, Sanggu
    Tan, Reginald B. H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 375 (1-2) : 84 - 88